ENGNW enGene Holdings Inc. - Warrants
NASDAQ · View on SEC EDGAR ↗ close Sep 29, 2026 10-K/10-Q Jun 15, 2026
$0.20
· of 52w range
· above low
· to high
$0.1852w low
$3.4852w high
Market Cap (MRQ)
$13M
EPS
$2.29
your badges
52W Range
$0–$3
Analyst Rating
·
Price Target
·
P/E
·
ROE
·
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
ENGNW Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.20
Market Cap (MRQ)
$13M
EPS
$2.29
Debt/Equity (MRQ)
0.0
52W Range
$0–$3
ENGNW Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
EPS$2.292022-10-31 → 2025-10-31
Free Cash Flow·2023-10-31 → 2023-10-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ENGNW | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/B (MRQ) | 0.1 | · | · | · | |
| EV / EBITDA (TTM) | 1.9 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ENGNW | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 0.0 | · | · | · | |
| Current Ratio (MRQ) | 12.6 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | ENGNW | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| EPS YoY | 56.9%5Y avg ≈66.4% | ≈66.4% | · | · | |
| EPS CAGR 3Y | -62.7% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| R&D Expense | $94M | $38M | $16M | $15M | |
| SG&A Expense | $29M | $24M | $10M | $4M | |
| Operating Expenses | $123M | $62M | $26M | $19M | |
| Operating Income | $-123M | $-62M | $-26M | $-19M | |
| Interest Expense | · | · | $5M | $1M | |
| Interest Income | $9M | $10M | $1M | $129.0K | |
| Other Non-op | $-569.0K | $-113.0K | $-129.0K | $-662.0K | |
| Pretax Income | $-117M | $-55M | $-100M | $-24M | |
| Income Tax | $0 | $-19.0K | $17.0K | $22.0K | |
| Net Income | $-117M | $-55M | $-100M | $-24M | |
| EPS (Basic) | $2.29 | $1.46 | $151.22 | $44.30 | |
| EPS (Diluted) | $2.29 | $1.46 | $151.22 | $44.30 | |
| Shares (Basic) | 51,119,479 | 37,782,346 | 692,609 | 655,153 | |
| Shares (Diluted) | 51,119,479 | 37,782,346 | 692,609 | 655,153 | |
| EBITDA | · | · | $-26M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $50M | $173M | $82M | $20M | |
| Short-term Investments | $144M | $65M | · | · | |
| Prepaid Expense | $7M | $9M | $2M | $739.0K | |
| Current Assets | $201M | $247M | $85M | $23M | |
| PP&E (Net) | $2M | $1M | $589.0K | $387.0K | |
| PP&E (Gross) | $5M | $3M | $2M | $2M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $1M | $1M | $930.0K | $939.0K | |
| Total Assets | $221M | $311M | $87M | $24M | |
| Accounts Payable | $7M | $1M | $1M | $723.0K | |
| Short-term Debt | $8M | $699.0K | $562.0K | $1M | |
| Current Liabilities | $32M | $15M | $5M | $5M | |
| Capital Leases | $6M | $1M | · | · | |
| Total Liabilities | $54M | $39M | $14M | $47M | |
| Total Debt | · | · | $562.0K | · | |
| Common Stock | $513M | $510M | $259M | $16M | |
| Retained Earnings | $-372M | $-255M | $-200M | $-100M | |
| AOCI | $-888.0K | $-1M | $-1M | $-1M | |
| Stockholders' Equity | $168M | $273M | $72M | $-77M | |
| Liabilities + Equity | $221M | $311M | $87M | $24M | |
| Shares Outstanding | 52,018,658 | 50,976,676 | 23,197,976 | 665,767 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $500.0K | $300.0K | $200.0K | $200.0K | |
| Stock-based Comp | $10M | $5M | $3M | $116.0K | |
| Other Non-cash | · | · | $72M | · | |
| Operating Cash Flow | $-99M | $-48M | $-25M | $-18M | |
| CapEx | $1M | $925.0K | $318.0K | $153.0K | |
| Investing Cash Flow | $-25M | $-126M | $-318.0K | $-153.0K | |
| Dividends Paid | · | · | $0 | · | |
| Financing Cash Flow | $2M | $266M | $86M | $28M | |
| Net Change in Cash | $-123M | $91M | $61M | $9M | |
| Free Cash Flow | · | · | $-25M | · | |
| Levered FCF | · | · | $-30M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| ROA | · | · | -180.2% | · | |
| ROE | · | · | 932.3% | · | |
| ROIC | · | · | -35.7% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | · | · | 16.3 | · | |
| Quick Ratio | · | · | 15.5 | · | |
| Debt / Equity | · | · | 0.0 | · | |
| Interest Coverage | · | · | -5.3 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | · | · | $3.12 | · | |
| Cash Flow / Share | · | · | $-35.72 | · | |
| Cash / Share | · | · | $3.51 | · | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | · | |
| Dividend Paid / Share | $0.00 | $0.00 | $0.00 | · | |
| EPS (TTM) | $2.29 | $1.46 | $151.22 | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| EPS YoY | 56.9% | -99.0% | 241.3% | · | |
| EPS CAGR 3Y | -62.7% | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Net Income TTM | $-117M | $-55M | $-100M | · | |
| Payout Ratio | · | · | 0.00% | · | |
| Annual Payout | · | · | $0 | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 | Q1 2025 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $22M | $22M | $32M | $23M | $20M | $13M | $12M | $4M | |
| SG&A Expense | $10M | $9M | $8M | $7M | $7M | $9M | $5M | $2M | |
| Operating Expenses | $32M | $31M | $39M | $30M | $27M | $22M | $17M | $6M | |
| Operating Income | $-32M | $-31M | $-39M | $-30M | $-27M | $-22M | $-17M | $-6M | |
| Interest Income | $3M | $3M | $2M | $2M | $2M | $4M | $3M | $394.0K | |
| Other Non-op | $-177.0K | $-87.0K | $-121.0K | $-280.0K | $-205.0K | $282.0K | $-47.0K | $-439.0K | |
| Pretax Income | $-30M | $-30M | $-38M | $-29M | $-26M | $-21M | $-14M | $-5M | |
| Income Tax | $0 | $0 | $-497.0K | $239.0K | $240.0K | $-11.0K | $-29.0K | $0 | |
| Net Income | $-30M | $-30M | $-38M | $-29M | $-26M | $-15M | $-14M | $-5M | |
| EPS (Basic) | $-0.43 | $0.44 | $0.73 | $0.57 | $-0.51 | $-7.79 | $0.32 | $8.55 | |
| EPS (Diluted) | $-0.43 | $0.44 | $0.73 | $0.57 | $-0.51 | $-7.79 | $0.32 | $8.55 | |
| Shares (Basic) | 69,724,761 | 67,263,234 | · | 51,097,711 | 51,019,363 | · | 44,168,986 | 701,323 | |
| Shares (Diluted) | 69,724,761 | 67,263,234 | · | 51,097,711 | 51,019,363 | · | 44,168,986 | 701,323 | |
| EBITDA | $-32M | $-31M | · | $-30M | $-27M | · | $-17M | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 | Q1 2025 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $30M | $37M | $50M | $33M | $58M | $173M | $258M | · | |
| Short-term Investments | $229M | $239M | $144M | $169M | $160M | $65M | · | · | |
| Prepaid Expense | $11M | $12M | $7M | $9M | $10M | $9M | $5M | · | |
| Current Assets | $270M | $289M | $201M | $211M | $228M | $247M | $263M | · | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $1M | $1M | · | |
| PP&E (Gross) | $5M | $5M | $5M | $4M | $3M | $3M | $3M | · | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | |
| Other Non-current Assets | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | |
| Total Assets | $308M | $337M | $221M | $246M | $267M | $311M | $267M | · | |
| Accounts Payable | $2M | $2M | $7M | $2M | $2M | $1M | $3M | · | |
| Short-term Debt | $193.0K | $188.0K | $8M | $5M | $4M | $699.0K | $1M | · | |
| Current Liabilities | $21M | $25M | $32M | $20M | $18M | $15M | $13M | · | |
| Capital Leases | $6M | $6M | $6M | $7M | $1M | $1M | $1M | · | |
| Total Liabilities | $52M | $56M | $54M | $45M | $39M | $39M | $37M | · | |
| Total Debt | $193.0K | $188.0K | · | $5M | $4M | · | · | · | |
| Common Stock | $632M | $632M | $513M | $510M | $510M | $510M | $453M | · | |
| Retained Earnings | $-432M | $-402M | $-372M | $-334M | $-305M | $-255M | $-239M | · | |
| AOCI | $-1M | $-842.0K | $-888.0K | $-1M | $-969.0K | $-1M | $-1M | · | |
| Stockholders' Equity | $255M | $282M | $168M | $201M | $227M | $273M | $230M | · | |
| Liabilities + Equity | $308M | $337M | $221M | $246M | $267M | $311M | $267M | · | |
| Shares Outstanding | 66,989,466 | 66,989,466 | 52,018,658 | 51,105,807 | 51,070,851 | 50,976,676 | 44,215,577 | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 | Q1 2025 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $200.0K | $189.0K | $198.0K | $100.0K | $100.0K | $57.0K | $100.0K | $43.0K | |
| Stock-based Comp | $4M | $3M | $3M | · | $3M | $2M | · | · | |
| Other Non-cash | · | $-2M | · | · | · | · | · | · | |
| Operating Cash Flow | $-30M | $-29M | $-25M | · | $-23M | $-20M | · | · | |
| CapEx | $98.0K | $153.0K | $437.0K | · | $45.0K | $238.0K | · | · | |
| Investing Cash Flow | $24M | $-126M | $40M | · | $18M | $-125M | · | · | |
| Financing Cash Flow | $74.0K | $142M | $2M | · | $199.0K | $60M | · | · | |
| Net Change in Cash | $-7M | $-14M | $18M | · | $-5M | $-85M | · | · | |
| Free Cash Flow | · | $-29M | · | · | · | · | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 | Q1 2025 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.5% | -9.6% | · | -11.3% | -9.6% | · | · | · | |
| ROE | -12.5% | -11.2% | · | -13.5% | -11.0% | · | · | · | |
| ROIC | -12.5% | -11.1% | · | -14.6% | -11.9% | · | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 | Q1 2025 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.6 | 11.8 | · | 10.3 | 12.7 | · | · | · | |
| Quick Ratio | 12.0 | 11.2 | · | 9.9 | 12.1 | · | · | · | |
| Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 | Q1 2025 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.81 | $4.20 | · | $3.93 | $4.45 | · | · | · | |
| Cash Flow / Share | · | $-0.43 | · | · | · | · | · | · | |
| Cash / Share | $0.45 | $0.55 | · | $0.64 | $1.13 | · | · | · | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | · | · | · | · | · | |
| Dividend Paid / Share | $0.00 | $0.00 | $0.00 | · | · | · | · | · | |
| EPS (TTM) | $1.31 | $1.23 | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 | Q1 2025 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-127M | $-122M | · | · | · | · | · | · | |
| Market Cap | $149M | · | · | · | · | · | · | · | |
| Enterprise Value | $-109M | · | · | · | · | · | · | · | |
| P/E | 1.7 | · | · | · | · | · | · | · | |
| P/B | 0.6 | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.6 | · | · | · | · | · | · | · | |
| Earnings Yield | 58.7% | · | · | · | · | · | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 |
|---|---|---|---|---|
| Net Income | $-117M | $-55M | $-100M | $-24M |
| Diluted EPS | $2.29 | $1.46 | $151.22 | $44.30 |
| Metric | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 |
|---|---|---|---|---|
| Debt / Equity | · | · | 0.0 | · |
| Current Ratio | · | · | 16.3 | · |
| Quick Ratio | · | · | 15.5 | · |
| Metric | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 |
|---|---|---|---|---|
| Free Cash Flow | · | · | $-25M | · |
Institutional owners (13F) 2 filers · $835K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
2
Value held
$835K
New positions
0
Exited positions
11
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 0 | 11 | 0 | 0 | · |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair. Change vs prior quarter not shown: filer coverage differs too much between these two quarters for a reliable comparison.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| FCPM III SERVICES B.V. | $834,376 | 2,878,148 | 99.97% | Shares |
| CLEAR STREET LLC | $246 | 300 | 0.03% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Forbion Growth Sponsor FEAC I B.V., Forbion Growth Opportunities Fund I Cooperatief U.A., Forbion Growth Management B.V. | Nov. 13, 2023 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 8 insiders · 1 officers · 8 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| William Grossman | Interim Chief Medical Officer | Sept. 22, 2026 P | 5,102 | 1 | 0 | $10,051 |
| Wouter Joustra | Director | June 16, 2026 A | · | 0 | 0 | $0 |
| Michael Thomas Heffernan | Director | June 16, 2026 A | · | 0 | 0 | $0 |
| Gerald A Brunk | Director | June 16, 2026 A | · | 0 | 0 | $0 |
| Philip Astley-Sparke | Director | June 16, 2026 A | · | 0 | 0 | $0 |
| Richard M Glickman | Director | June 16, 2026 A | · | 0 | 0 | $0 |
| Paul J Hastings | Director | June 16, 2026 A | · | 0 | 0 | $0 |
| Lota S. Zoth | Director | June 16, 2026 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Jun 15, 2026